Previous 10 | Next 10 |
SOLANA BEACH, Calif. and CHICAGO, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company primarily focused on treatments for gastrointestinal (GI) diseases, and EVERSANA™, an independent provider of global commercial services to the li...
Evoke Pharma, Inc. (EVOK) Q2 2022 Earnings Conference Call August 10, 2022 4:30 PM ET Company Participants David Gonyer – Chief Executive Officer Chris Quesenberry – Chief Commercial Officer Matthew D’Onofrio – Chief Business Officer ...
Evoke Pharma press release ( NASDAQ: EVOK ): Q2 GAAP EPS of -$0.71 (vs. -$0.85 Y/Y). Revenue of $0.46M (+91.7% Y/Y). For further details see: Evoke Pharma Q2 GAAP loss per share narrows, revenue up
SOLANA BEACH, Calif., Aug. 10, 2022 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases, today announced its financial results for the second quarter ended June 30, 2022, and recent corp...
SOLANA BEACH, Calif., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that the Company is scheduled to release its second quarter on Wednesday, August 10, 2...
Ranked #1 in IFFGD Virtual Walk to spread awareness and support research for gastrointestinal disorders Evoke attending ANMS 2022 meeting August 5-7 in Philadelphia, PA SOLANA BEACH, Calif., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specia...
Evoke Pharma ( NASDAQ: EVOK ) said the Canadian Intellectual Property Office granted a patent covering methods of use for nasal delivery of Gimoti's formulation, metoclopramide, to treat diabetic gastroparesis (DG). The patent titled “Nasal Formul...
SOLANA BEACH, Calif., July 06, 2022 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI® (metoclopramide) nasal spray, today announced that the Canadian I...
Addex Therapeutics (ADXN) -36% after terminating lead program. ToughBuilt Industries (TBLT) -28%. Advent Technologies (ADN) -13%. Comera Life Sciences (CMRA) -9%. Sidus Space (SIDU) -8%. Aethlon Medical (AEMD) -8%. Rhythm Pharmaceuticals (RYTM) -4% after FDA rejects Rhythm...
3 Penny Stocks That Exploded During Trading Today If you’re looking for the best penny stocks to buy, there are hundreds to choose from. And after several days of bearish market trading, we are seeing some penny stocks with explosive gains right now. Although it is hard and n...
News, Short Squeeze, Breakout and More Instantly...
A look at the top 10 most actives in the United States Agrify Corporation (AGFY) rose 164.2% to $0.6658 on volume of 125,460,313 shares NVIDIA Corporation (NVDA) fell 2.9% to $122.88 on volume of 51,163,891 shares Crown Electrokinetics Corp. (CRKN) fell 0.3% to $0.04097 on volume of 44,45...
A look at the top 10 most actives in the United States Mustang Bio Inc. (MBIO) rose 141.4% to $0.3138 on volume of 161,736,322 shares ENDRA Life Sciences Inc. (NDRA) rose 13.7% to $0.117778 on volume of 79,058,950 shares AgriFORCE Growing Systems Ltd. (AGRI) rose 27.2% to $0.1042 on volum...
Expanded State Medicaid Access for GIMOTI Achieved highest ever monthly GIMOTI prescription fills in May 2024 Promoted former VP of Finance, Mark Kowieski to Chief Financial Officer SOLANA BEACH, Calif., June 17, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK)...